CNR1 and endometrium adenocarcinoma: Antiproliferative and pro-apoptotic effects of the CB1/CB2 receptors activation were also investigated on two cell lines from endometrial adenocarcinoma (Ishikawa cell line) and ovarian endometrioma (CRL-7566 immortalized stromal cells).